Search
for
Sort by
Research 31–60 of 388
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Advances in the mechanism and new therapies of alopecia areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Ritlecitinib: First Approval
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Hair Follicle Reconstruction and Stem Cells
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration
- Janus kinase inhibitors for alopecia areata: A narrative review
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East